Palisade Bio Inc’s latest rating changes from various analysts

Palisade Bio Inc’s recently made public that its CEO, CFO, Director Finley John David acquired Company’s shares for reported $4692.0 on Feb 06 ’24. In the deal valued at $0.47 per share,10,000 shares were bought. As a result of this transaction, Finley John David now holds 84,649 shares worth roughly $31320.13. Then, Williams Donald Allen […]

PALI short interest fall by -27.92%, reflecting positive sentiment

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Palisade Bio Inc shares valued at $4,692 were purchased by Finley John David on Feb 06. At $0.47 per share, Finley John David acquired 10,000 shares. The insider’s holdings grew to […]

Palisade Bio Inc’s latest rating changes from various analysts

In a filing, Palisade Bio Inc revealed its CEO, CFO, Director Finley John David acquired Company’s shares for reported $4692.0 on Feb 06. In the deal valued at $0.47 per share,10,000 shares were bought. As a result of this transaction, Finley John David now holds 84,649 shares worth roughly $36399.07. Then, Williams Donald Allen bought […]

Taking a Closer Look At Palisade Bio Inc (PALI) Following Its Recent Trade

Palisade Bio Inc’s recently made public that its CEO, CFO, Director Finley John David acquired Company’s shares for reported $4692.0 on Feb 06. In the deal valued at $0.47 per share,10,000 shares were bought. As a result of this transaction, Finley John David now holds 84,649 shares worth roughly $36399.07. Then, Williams Donald Allen bought […]

Do Analysts Think Palisade Bio Inc. (PALI) Is Still Worth Buying In 2023?

Palisade Bio Inc. (NASDAQ:PALI) does about 3.63M shares in volume on a normal day but saw 277025 shares change hands in Friday trading. The company now has a market cap of 3.40M USD. Its current market price is $2.31, marking a decrease of -3.35% compared to the previous close of $2.39. The 52 week high […]